Changeflow GovPing Healthcare & Life Sciences University Aberdeen Eukaryotic Cell Translocati...
Routine Rule Added Final

University Aberdeen Eukaryotic Cell Translocation Method

Favicon for changeflow.com EPO Patent Bulletin - Peptides (C07K)
Published
Detected
Email

Summary

The European Patent Office published application EP3802618A1 on April 15, 2026, titled 'Translocation Into Eukaryotic Cells,' filed by The University Court of The University of Aberdeen. Inventors are Franziska Trusch and Pieter van West. The application covers peptide-based eukaryotic cell translocation methods under IPC classifications including C07K 17/14, A61K 47/62, and A61K 39/00, with designated states spanning all 31 EEA/EPC contracting states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 34 changes logged to date.

What changed

The EPO published European patent application EP3802618A1 for The University Court of The University of Aberdeen, covering methods and compositions for translocating peptides into eukaryotic cells. The application is classified under IPC classes C07K (peptides), A61K (preparations for medical purposes), and A61P (therapeutic activity). The designated states cover all 31 EEA contracting states across the European Economic Area.

Competitors developing cell translocation technologies, peptide therapeutics, or gene therapy delivery systems should conduct freedom-to-operate analyses to assess potential overlap with the claimed subject matter. Universities and research institutions engaged in similar peptide delivery research may wish to review their own IP portfolios and consider whether cross-licensing or design-around strategies are warranted.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

TRANSLOCATION INTO EUKARYOTIC CELLS

Publication EP3802618A1 Kind: A1 Apr 15, 2026

Applicants

The University Court of The University of Aberdeen

Inventors

TRUSCH, Franziska, VAN WEST, Pieter

IPC Classifications

C07K 17/14 20060101AFI20191206BHEP A61K 47/62 20170101ALI20191206BHEP A61K 39/00 20060101ALI20191206BHEP C07K 14/37 20060101ALI20191206BHEP A61K 47/69 20170101ALI20191206BHEP A61P 11/00 20060101ALI20191206BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3802618A1

Who this affects

Applies to
Educational institutions Manufacturers Pharmaceutical companies
Industry sector
6111 Higher Education
Activity scope
Patent application publication Peptide formulation research Cell translocation technology
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!